CS logo
small CS logo
Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin

Jena, Germany
University hospital in Jena, Thuringia
Am Klinikum 1, 07747 Jena

About Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Vertex Pharmaceuticals Incorporated
9
University of Jena
4
Total Rows: 2

Clinical Trials at Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin


During the past decade, Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33221100110000112211Started TrialsCompleted Trails2018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
2007-09-01
2009-02-01
Completed
23
Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization
2008-10-01
2010-11-01
Completed
9
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
2009-06-01
2012-11-01
Completed
167
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation
2009-08-01
2011-04-01
Completed
52
Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization
2009-12-01
2012-04-01
Completed
10
Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
2010-03-01
2013-06-01
Completed
69
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
2018-03-07
2019-02-05
Completed
385
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
2018-07-13
2020-09-09
Terminated
484

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin" #1 collaborator was "Cystic Fibrosis Foundation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsVertex PharmaceuticalsIncorporated: 9Vertex PharmaceuticalsIncorporated: 9University of Jena: 4University of Jena: 4

Created with Highcharts 11.1.0Top CollaboratorsCystic Fibrosis Foundation: 2Cystic Fibrosis Foundation: 2

Clinical Trials Conditions at Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin


According to Clinical.Site data, the most researched conditions in "Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin" are "Cystic Fibrosis" (13 trials), "Pseudomonas Aeruginosa" (2 trials) and "Rhinosinusitis" (2 trials). Many other conditions were trialed in "Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin" in a lesser frequency.

Clinical Trials Intervention Types at Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin


Most popular intervention types in "Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "IVA" (7 trials), "ELX/TEZ/IVA" (4 trials), "Placebo" (3 trials), "Ivacaftor" (2 trials) and "TEZ/IVA" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin


The vast majority of trials in "Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin" are 13 trials for "All" genders.

Clinical Trials Status at Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin


Currently, there are NaN active trials in "Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Mukeviszidose-Zentrum am Universitatsklinikum Jena, Klinik fuer Kinder- und Jugendmedizin, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 10Phase 3: 10Phase 2: 2Phase 2: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Active, not recruiting: 2Active, not recruiting: 2Terminated: 1Terminated: 1